Cleveland, OH – According to filings with the U.S. Securities and Exchange Commission, Aatru Medical is raising $5,000,769.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tim Wojciechowski played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Aatru Medical
Aatru Medical, LLC (Aatru) is a privately-held medical device company specializing in technology development in negative pressure wound therapy for surgical incisions and chronic wounds. The Aatru NPSIMS represents a new and advanced technology in ultraportable devices that are designed for use on closed surgical incisions that produce low exudate. A 510(k) premarket notification submission was filed in June 2020 with the US FDA. The NPSIMS product does not have FDA Clearance and is not for sale at this time. All information on this website is for educational purposes only.

To learn more about Aatru Medical, visit http://aatru.com/

Contact:
Tim Wojciechowski, Chief Executive Officer
216-303-6063
https://www.linkedin.com/in/tim-wojciechowski-69643a13/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved